Literature DB >> 27912080

The Itch ubiquitin ligase is required for KSHV RTA induced vFLIP degradation.

Jennifer C Chmura1, Kevin Herold1, Ayana Ruffin1, Trudymae Atuobi1, Yetunde Fabiyi1, Ashley E Mitchell1, Young Bong Choi2, Elana S Ehrlich3.   

Abstract

Expression of Kaposi's sarcoma herpesvirus vFLIP, a potent activator of NFkB signaling, promotes latency. Inhibition of NFkB signaling promotes lytic reactivation. We previously reported that lytic inducer, RTA, inhibits vFLIP induced NFkB signaling by inducing the degradation of vFLIP via the proteasome. Here we report that the cellular ubiquitin ligase, Itch, is required for RTA induced degradation of vFLIP. Expression of either Itch targeting shRNA or a dominant negative mutant of the ubiquitin ligase both increased the stability of vFLIP in the presence of RTA. Itch potently ubiquitinated vFLIP in vivo and in vitro. We provide evidence for interaction between RTA, vFLIP and Itch and we identified an RTA resistant mutant of vFLIP that is unable to interact with Itch. These observations contribute to our understanding of how RTA counteracts the activities of vFLIP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIP4; HHV-8; Herpesvirus; Itch; KSHV; Kaposi's sarcoma; NF-κB; RTA; Ubiquitin; vFLIP

Mesh:

Substances:

Year:  2016        PMID: 27912080      PMCID: PMC5271570          DOI: 10.1016/j.virol.2016.11.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.

Authors:  W Zhong; H Wang; B Herndier; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors.

Authors:  M Thome; P Schneider; K Hofmann; H Fickenscher; E Meinl; F Neipel; C Mattmann; K Burns; J L Bodmer; M Schröter; C Scaffidi; P H Krammer; M E Peter; J Tschopp
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

3.  Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.

Authors:  Olsi Gjyshi; Stephanie Flaherty; Mohanan Valiya Veettil; Karen E Johnson; Bala Chandran; Virginie Bottero
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

4.  The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex.

Authors:  Li Liu; Michael T Eby; Nisha Rathore; Suwan K Sinha; Arvind Kumar; Preet M Chaudhary
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

5.  NF-kappaB inhibits gammaherpesvirus lytic replication.

Authors:  Helen J Brown; Moon Jung Song; Hongyu Deng; Ting-Ting Wu; Genhong Cheng; Ren Sun
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 6.  KSHV infection and the pathogenesis of Kaposi's sarcoma.

Authors:  Don Ganem
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

7.  A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.

Authors:  M Schalling; M Ekman; E E Kaaya; A Linde; P Biberfeld
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

8.  Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.

Authors:  Faye Gould; Sally M Harrison; Eric W Hewitt; Adrian Whitehouse
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

9.  KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome.

Authors:  Elana S Ehrlich; Jennifer C Chmura; John C Smith; Nene N Kalu; Gary S Hayward
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

10.  Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.

Authors:  Hong Seok Choi; Vaibhav Jain; Brian Krueger; Vickie Marshall; Chang Hee Kim; Joanna L Shisler; Denise Whitby; Rolf Renne
Journal:  PLoS Pathog       Date:  2015-11-06       Impact factor: 6.823

View more
  6 in total

Review 1.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

2.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

3.  KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.

Authors:  Lauren R Combs; Lauren McKenzie Spires; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

4.  KSHV RTA antagonizes SMC5/6 complex-induced viral chromatin compaction by hijacking the ubiquitin-proteasome system.

Authors:  Chunyan Han; Dun Zhang; Chenwu Gui; Liang Huang; Sijia Chang; Lianghui Dong; Lei Bai; Shuwen Wu; Ke Lan
Journal:  PLoS Pathog       Date:  2022-08-01       Impact factor: 7.464

5.  CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.

Authors:  Richard Hunte; Patricia Alonso; Remy Thomas; Cassandra Alexandria Bazile; Juan Carlos Ramos; Louise van der Weyden; Juan Dominguez-Bendala; Wasif Noor Khan; Noula Shembade
Journal:  PLoS Pathog       Date:  2018-04-26       Impact factor: 6.823

6.  Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics.

Authors:  Jouliana Sadek; Michael G Wuo; David Rooklin; Arthur Hauenstein; Seong Ho Hong; Archana Gautam; Hao Wu; Yingkai Zhang; Ethel Cesarman; Paramjit S Arora
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.